Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe you are correct. Maybe the Jewish Hospital at McGill University and the University of Georgia's Pharmacy School like to run scams on the side to supplement their income. You could be right.
Anybody who can read can see that IND studies and Fast Track are next for both medicines. That means that the mice trials were successful.
I think everything you write here may be correct. With multiple Fed rate hikes looming, this is indeed a bad time to invest in the stock market.
Aegis is not dumb however. When they put this book together they did it with one thing in mind. They want investors who are likely to hold on to their shares because Aegis will have warrants at a higher strike price and they become tradable/sellable in 6 months.
Still, the wild card that you discount is the science. This is not CELZ. This is transformative medicine. If Slilaty succeeds with either drug in the Fast Track process this is headed to a billion dollar valuation.
Tenkay called this a scam. Of course she thinks those buying in to the offering will dump their new shares and warrants.
She doesn't know that two entities are taking half the shares. The vast majority of buyers are medical science investors who understand the implications of Slilaty's IP.
Some will buy in to get the warrants and dump the shares. Almost all though are going long for the possibility of two Fast Track approvals.
Some will, most won't. Medical science funds are not buying to flip shares. They are buying for the science.
Yes, the 1.9 million in debt is getting cleared off the books so a dividend is possible. That sounds pretty solid to me.
So the police will put my shares back in my computer how? The air vents?
What if I trade on my cell phone? Thanks in advance.
We did get updates. Everything we needed to know was in the filings and legal documents.
We learned that the mice trials for Adva and Pl4 were successful. We learned that Fast Track applications will be made for both drugs.
The fact that most OTCBB investors don't understand what is going on is not the fault of the company. There is a reason why we are moving out of this neighborhood (cue the theme song to The Jeffersons).
Just remember, if you call the Kraken then you will have to clean up the mess.
That is 100% incorrect. The reason for the RS was to get to Nasdaq. They had acceptance and then they split. I know this for a fact.
I am not even sure we need news. The people who understand this can't buy until Tuesday anyway. The float is so small and the market cap is so small that we can sustain until Fast Track applications are announced imo.
I know for a fact that funds are buying in the offering. There will be more over the next two weeks. This will be a roller coaster ride for a couple of weeks but we should be happy around March 1.
Yes, SBFMD will be on the Nas next week with a 3.3 million float.
Aegis is closing the book today. Nasdaq probably Monday, no later than Tuesday.
This dividend is a big blinking neon sign that says to savvy investors and funds- LOOK AT ME.
The dividend is a declaration that all debt will be off the books. Company can't issue a dividend to shareholders otherwise (they get paid last). This is not really for us, imo. This is to show Funds and Institutions that our books are in order. It is a great move.
SBFMD- issuing dividend, Nasdaq uplist no later than Tuesday, applying for Fast Track for a non-toxic Protease Inhibitor for Coronaviruses and a new drug that kills chemo resistant cancer in the lab and mice. 3.3 million float.
The closing price was 8.50.
The price you see is not correct. The last sale was 8.50 and the bid was rising all day. This is really more like .043 split adjusted and going back up.
I could see a dip. There will no doubt be investor who sell the new shares and just keep the warrants. Good luck to you getting a good reentry point.
The last price is 8.50 but that is not being shown.
lol, I can assure you of one thing- there is A LOT that I don't know.
Are you sure? The D might be a 20 day thing.
oh, how wrong you are. You will see- there is actual institutional interest in Dr. Slilaty's protease inhibitor.
I won't take that bet. ;)
I would like to hear from posters who said the company would never get to the Nasdaq. They should go first.
Really People likes boy bands.
Read this morning's filing. Sunshine is approved.
I am, but the price right now doesn't matter. Let's chat again March 1. That will be a better indicator. Also, thank you for supporting this stock. ;)
Sunshine is approved for the Nasdaq. This is great news.
Holy smoke! That is a perfect name for your yacht.
Hey Homebrew, I guess now that Sunshine is approved for the Nasdaq you must be very happy for shareholders here. Right?
I had a nice talk with the Aegis roadshow team today be and I feel pretty damn good about where we are sitting. I feel way more comfortable holding these shares for 2022. People who trade in and out of this stock potentially will be very sorry in my opinion.
The otcbb is not representative of the market. There are plenty of people who can't buy a pink sheet stock. Investment funds, like the ones who view Aegis' road show, won't buy a penny stock which is defined as a stock under $5 a share. After the Nasdaq uplist we will see what the market thinks.
No, my point was that after the road show ends we will know if the investors are impressed with Slilaty or not. That feedback will tell me if this was a good investment. Nothing anybody writes on this board actually means a thing because the free market is going to give us the answers we need soon. I have been reading your posts for over a year and I think you deserve a happy ending here. I hope we get one. I am confident that we will.
I don't care. I only care about the market cap in March. That will tell the story. The funds and investors who view the roadshow material that Aegis is promoting will let us know if buying this stock was a good or bad decision. The waiting game is coming to an end. Come back mid March and chat then.
yeah...the shares in our accounts have not finished reconciliation, but you think what you want. LOL, I can't wait to get on the Nasdaq.
Of course the stock price could go there. We would then have a forward split to bring the price down. The stock price will reflect the market cap, and if we cure one pancreatic cancer patient then this market cap is going through the roof.
Aegis is going to sell some shares. We will see some appreciation for sure going into March. This is simple supply and demand. A larger potential group of buyers equals greater demand.